Patent-Linked Exclusivity .

1. Introduction

Parallel imports (also called grey-market imports) occur when genuine products are imported into a country without the authorization of the intellectual-property owner or its authorized distributor in that country.

A parallel import restriction is a contractual, trademark, copyright, patent, distribution, or regulatory measure designed to prevent or limit such imports.

Competition law is concerned with these restrictions because they can divide markets geographically, prevent arbitrage, maintain price differences between countries, and protect exclusive distributors from competition. At the same time, intellectual-property law may permit an IP owner to control the first sale or importation of protected goods, depending on the applicable exhaustion regime.

The central competition-law question is therefore:

When does legitimate protection of intellectual-property rights become an anticompetitive territorial market-partitioning strategy?

2. Meaning of Parallel Imports

Suppose a manufacturer sells the same branded product for:

  • ₹100 in Country A; and
  • ₹160 in Country B.

An independent trader purchases genuine products in Country A and imports them into Country B for ₹130.

The importer is not selling counterfeit products. The goods are genuine, but they have entered Country B outside the manufacturer's authorized distribution network.

This is a parallel import.

Parties commonly involved

  1. IP owner/manufacturer
  2. Authorized national distributor
  3. Parallel importer
  4. Retailers
  5. Consumers

The manufacturer may attempt to stop the parallel importer through:

  • territorial distribution agreements;
  • exclusive-distribution arrangements;
  • trademark litigation;
  • copyright claims;
  • patent claims;
  • contractual restrictions;
  • selective-distribution systems;
  • resale restrictions;
  • customs enforcement;
  • technological restrictions;
  • warranty restrictions;
  • differential product versions.

3. Parallel Imports and Competition Law

Parallel imports can have a pro-competitive function.

They allow traders to purchase goods where prices are lower and resell them where prices are higher. This process is essentially cross-border arbitrage.

It may:

  • reduce national price differences;
  • increase consumer choice;
  • undermine artificial territorial monopolies;
  • constrain authorized distributors;
  • encourage price competition;
  • prevent manufacturers from maintaining excessive geographic price discrimination.

However, parallel imports can also create legitimate commercial concerns.

Manufacturers may argue that different countries have:

  • different safety requirements;
  • different regulatory standards;
  • different packaging requirements;
  • different product specifications;
  • different warranty systems;
  • different labeling requirements;
  • different after-sales obligations.

Competition authorities therefore generally distinguish between genuine regulatory or IP-related restrictions and restrictions whose principal effect is to partition national markets.

4. Territorial Market Partitioning

One of the most important competition concerns is territorial partitioning.

Consider:

Manufacturer → Distributor A → Country A
Manufacturer → Distributor B → Country B

If the manufacturer tells Distributor A:

"You must not sell to customers in Country B."

and tells Distributor B:

"You must not accept products originating from Country A."

the combined effect may be to create two geographically insulated markets.

This can allow the manufacturer and distributors to maintain different prices in the two markets.

Competition concern

Territorial restrictions become particularly problematic where they:

  • prevent passive sales;
  • prevent unsolicited cross-border purchases;
  • prohibit distributors from responding to foreign customers;
  • impose penalties for cross-border sales;
  • monitor destination countries;
  • terminate distributors who supply parallel traders;
  • coordinate distributors to prevent imports.

5. Active Sales and Passive Sales

A major distinction in distribution law is between active and passive sales.

Active sales

A distributor deliberately targets customers in another territory.

Examples:

  • advertising specifically to customers in another country;
  • establishing a foreign-language website targeting another territory;
  • contacting foreign customers directly;
  • maintaining sales representatives abroad.

Passive sales

The customer independently approaches the distributor.

For example:

A German customer finds a French distributor online and voluntarily purchases the product from France.

A contractual provision saying:

"The distributor shall not respond to unsolicited orders from customers located outside its territory"

can raise serious competition concerns because it restricts passive sales.

6. Exhaustion of Intellectual-Property Rights

Parallel-import disputes frequently turn on exhaustion.

Exhaustion means that after an IP-protected product has been lawfully placed on a relevant market by or with the consent of the IP owner, the owner may lose the ability to use the IP right to control subsequent resale of that particular product.

Three broad systems are commonly discussed.

A. National exhaustion

Exhaustion occurs only when the product is first sold domestically.

The IP owner may therefore generally use the IP right to prevent imports from another country.

B. Regional exhaustion

Exhaustion occurs after first lawful sale anywhere within a particular regional market.

For example, under an applicable regional regime, a product lawfully sold in one member state may subsequently circulate within the region.

C. International exhaustion

A lawful first sale anywhere in the world may exhaust the relevant IP right, subject to the applicable legal framework.

This can make parallel imports substantially easier.

7. Competition-Law Issues

Parallel-import restrictions can generate several different competition-law theories.

A. Absolute territorial protection

An agreement completely preventing cross-border sales may amount to a serious territorial restriction.

The concern is particularly strong where distributors are prevented from supplying customers who independently approach them.

B. Export bans

A manufacturer may prohibit an authorized distributor from selling outside its assigned territory.

An export restriction can become problematic when it protects geographically separated markets.

C. Import bans

A manufacturer may attempt to prevent products purchased abroad from being imported into another country.

This can be implemented through:

  • contractual restrictions;
  • trademark enforcement;
  • distributor agreements;
  • customs measures;
  • warranty restrictions.

The competition analysis depends on the relevant IP regime and the actual commercial effects.

D. Dual pricing

A manufacturer may charge different prices to distributors depending on their intended territory.

For example:

TerritoryWholesale price
Country A₹100
Country B₹160

If the pricing system is designed specifically to prevent arbitrage, competition authorities may examine whether it facilitates territorial market partitioning.

E. Selective distribution

A manufacturer may permit sales only through approved distributors.

Selective distribution is not automatically unlawful.

The key questions include:

  • Why is selection necessary?
  • Are criteria objective?
  • Are they applied consistently?
  • Are restrictions proportionate?
  • Do they unnecessarily exclude parallel traders?
  • Does the system reduce inter-brand or intra-brand competition?

8. Six Important Case Laws

1. Silhouette International Schmied GmbH & Co. KG v Hartlauer Handelsgesellschaft mbH (1998)

Facts

Silhouette manufactured spectacles and sold them outside the European Economic Area. Hartlauer sought to sell those genuine products within Austria.

Silhouette relied upon its trademark rights to prevent the imports.

Issue

Whether trademark exhaustion applied to goods first marketed outside the EEA.

Decision

The European Court of Justice held that the EU trademark regime operated on the basis of Community/EEA exhaustion rather than international exhaustion.

Therefore, marketing goods outside the EEA did not automatically exhaust the trademark owner's rights within the EEA.

Competition significance

The case demonstrates the importance of distinguishing:

  • IP exhaustion; and
  • competition-law restrictions.

An IP owner may possess a legitimate right to prevent certain imports under the applicable exhaustion regime.

Principle

The legality of parallel imports cannot be determined solely by competition law; the applicable exhaustion regime is fundamental.

2. Sebago Inc. v GB-Unic SA (1999)

Facts

Sebago products were marketed outside the EEA and subsequently imported into the EEA without the trademark owner's consent for the EEA market.

Issue

Whether prior marketing of identical branded goods outside the EEA exhausted the trademark rights inside the EEA.

Decision

The European Court of Justice rejected automatic exhaustion merely because the goods were genuine and had previously been marketed outside the EEA.

Competition significance

The judgment illustrates the limits of treating all genuine goods as freely importable.

A product can be genuine but still fall outside the relevant exhaustion regime.

Principle

Genuine goods do not necessarily mean unrestricted parallel importation.

3. Bristol-Myers Squibb v Paranova (1996)

Facts

Parallel importers sought to market pharmaceutical products in Denmark after purchasing them elsewhere within the EU. The products had to be repackaged and relabeled to comply with national requirements.

Issue

When can a trademark owner legitimately object to repackaging of parallel-imported goods?

Decision

The Court established important conditions governing repackaging and trademark objections.

A trademark owner could not simply invoke trademark rights to eliminate legitimate parallel trade where repackaging was necessary to obtain effective market access.

Competition significance

The judgment is particularly important for pharmaceuticals because technical trademark requirements can otherwise become a mechanism for blocking parallel imports.

Principle

IP rights should not be used beyond what is necessary to protect the legitimate function of the trademark.

4. Merck & Co. Inc. v Primecrown Ltd (1996)

Facts

Merck marketed pharmaceuticals at different prices in different EU Member States. Parallel traders purchased cheaper products in one Member State and imported them into another.

Issue

Whether patent rights could be used to prevent parallel imports within the EU.

Decision

The European Court considered the interaction between national patent rights and the Treaty rules concerning free movement and exhaustion.

The existence of national patent rights could not automatically justify restrictions designed to recreate national market barriers where the relevant exhaustion principles applied.

Competition significance

The case is significant because it shows how intellectual-property rights and market integration can conflict.

Principle

National IP rights cannot automatically be treated as a licence to recreate territorial barriers inside an integrated market.

5. GlaxoSmithKline Services Unlimited v Commission (2009)

Facts

GlaxoSmithKline operated a dual-pricing system for pharmaceutical products in Spain. The system differentiated prices depending on whether products were intended for domestic consumption or export.

The Commission regarded the arrangement as raising serious competition concerns because it could restrict parallel trade.

Decision

The EU courts examined the relationship between pharmaceutical pricing arrangements and parallel imports.

The case ultimately demonstrated that restrictions on parallel trade require careful analysis of both:

  • the restriction itself; and
  • its actual or potential effects.

Competition significance

It is a leading authority concerning dual pricing and parallel exports in pharmaceuticals.

Principle

A pricing system designed to discourage cross-border arbitrage can attract competition-law scrutiny.

6. Consten and Grundig v Commission (1966)

Facts

Grundig appointed Consten as its exclusive distributor in France and attempted to protect Consten's territorial exclusivity from parallel imports.

A trademark arrangement was also used to strengthen territorial protection.

Issue

Whether arrangements protecting an exclusive territory against parallel imports were compatible with EU competition law.

Decision

The European Court of Justice treated the arrangements as fundamentally problematic because they were designed to eliminate parallel imports and partition the common market.

Competition significance

This is one of the foundational cases concerning territorial market partitioning.

Principle

Agreements designed to isolate national markets and prevent parallel imports can constitute serious restrictions of competition.

9. Additional Important Authorities

7. United Brands v Commission (1978)

The case concerned the banana market and territorial distribution practices.

The Court examined restrictions affecting cross-border trade and emphasized the importance of preventing practices that compartmentalize markets.

Relevance

It remains important for understanding:

  • territorial restrictions;
  • distribution systems;
  • market integration;
  • abuse of dominance.

8. Van Binsbergen v Bestuur van de Bedrijfsvereniging (1974)

This broader free-movement authority illustrates the principle that national restrictions cannot unnecessarily obstruct cross-border economic activity.

Its importance in parallel-import analysis is contextual rather than directly concerning an IP-based parallel-import dispute.

9. Bayer AG v Commission (2004)

Facts

Bayer attempted to control the quantities of pharmaceuticals supplied to wholesalers in different EU countries, partly in response to parallel exports.

Significance

The case examined whether unilateral measures aimed at reducing parallel exports could constitute an agreement under EU competition law.

The Court emphasized the need to establish the existence of a genuine agreement or concerted practice rather than assuming that a unilateral policy automatically constitutes an Article 101 infringement.

Importance

This is especially useful when analysing pharmaceutical manufacturers' responses to parallel trade.

10. GlaxoSmithKline v Commission — Spanish Pharmaceuticals

This litigation is also important because it illustrates the difficulty of determining whether arrangements affecting parallel exports are:

  • restrictions by object;
  • restrictions by effect; or
  • potentially justified by legitimate economic considerations.

10. Parallel Imports and Dominant Firms

The issue becomes more serious when the manufacturer is dominant.

A dominant undertaking may potentially infringe competition law by using:

  • discriminatory supply conditions;
  • refusal to supply;
  • discriminatory warranties;
  • selective technical standards;
  • exclusionary contracts;
  • loyalty rebates;
  • discriminatory pricing;
  • IP litigation strategically;
  • contractual restrictions against parallel distributors.

Example

Suppose a dominant manufacturer tells authorized distributors:

"You may sell only to customers located in your assigned country."

The manufacturer simultaneously threatens termination if distributors respond to foreign customer requests.

The authority may examine whether the arrangement:

  1. protects legitimate distribution interests; or
  2. deliberately eliminates cross-border competition.

11. Parallel Imports in Pharmaceuticals

Pharmaceutical markets present particularly difficult issues.

Parallel traders may purchase medicines in a low-price jurisdiction and resell them in a high-price jurisdiction.

This can create tension between:

Manufacturer interests

  • R&D recovery;
  • national pricing regulation;
  • supply planning;
  • product safety;
  • pharmacovigilance.

Competition interests

  • lower prices;
  • greater availability;
  • arbitrage;
  • consumer welfare;
  • market integration.

Consequently, pharmaceutical parallel-import cases frequently involve:

  • repackaging;
  • relabeling;
  • trademark use;
  • supply quotas;
  • dual pricing;
  • export restrictions.

12. Parallel Imports and Trademarks

Trademark law has a particularly important role.

A trademark owner generally has an interest in ensuring that:

  • products are genuine;
  • packaging is not misleading;
  • the trademark is not altered improperly;
  • consumers receive accurate information.

However, trademark law should not automatically become a mechanism for suppressing lawful parallel trade.

Courts therefore frequently ask whether the trademark owner's objection protects a legitimate trademark function or simply prevents cross-border competition.

13. Parallel Imports and Copyright

Copyright can also be invoked against imported goods containing protected material.

Examples include:

  • software;
  • books;
  • games;
  • digital media;
  • educational materials;
  • packaging;
  • copyrighted labels.

Again, the applicable exhaustion regime determines whether the copyright owner can control subsequent distribution.

14. Parallel Imports and Patents

Patent exhaustion can be particularly complex.

Suppose a patented medical device is sold in Country A and subsequently imported into Country B.

Whether the patent owner can prevent the import depends upon the applicable law concerning:

  • territoriality;
  • exhaustion;
  • implied licence;
  • authorized sale;
  • contractual restrictions;
  • product modifications.

Patent rights therefore cannot be analysed independently of the jurisdiction's exhaustion doctrine.

15. Competition Analysis Framework

A competition authority examining parallel-import restrictions may proceed through the following framework:

Step 1 — Identify the relevant product market

Determine whether the products are:

  • interchangeable;
  • differentiated;
  • branded;
  • regulated.

Step 2 — Identify the geographic market

Determine whether markets are:

  • national;
  • regional;
  • international.

Step 3 — Identify the source of the restriction

Is it:

  • contractual?
  • unilateral?
  • IP-based?
  • regulatory?
  • technological?

Step 4 — Determine the market position

Examine:

  • market share;
  • barriers to entry;
  • distribution networks;
  • switching costs;
  • buyer power.

Step 5 — Examine the purpose/effect

Ask whether the restriction:

  • prevents parallel imports;
  • partitions territories;
  • reduces intra-brand competition;
  • protects investment;
  • prevents free riding;
  • addresses regulatory differences.

Step 6 — Consider efficiencies

Potential justifications may include:

  • product safety;
  • quality control;
  • investment incentives;
  • after-sales service;
  • regulatory compliance;
  • prevention of counterfeits.

Step 7 — Assess proportionality

The key question is whether the restriction goes further than reasonably necessary.

16. Legitimate vs Potentially Anticompetitive Restrictions

RestrictionCompetition concern
Preventing counterfeit importsGenerally legitimate objective
Genuine safety-based import restrictionsPotentially legitimate
Regulatory labeling requirementsPotentially legitimate
Prohibition on unauthorized alterationPotentially legitimate
Absolute territorial export banHigh competition concern
Ban on passive cross-border salesStrong concern
Distributor punishment for foreign customersPotential concern
Dual pricing aimed at stopping exportsSignificant concern
Coordination among distributors to block importsSignificant concern
Use of trademark solely to partition marketsPotential abuse/restriction
Selective distribution based on objective quality criteriaMay be legitimate
Selective distribution designed to exclude parallel tradersCompetition concern

17. Economic Effects

Parallel-import restrictions can produce several economic effects.

Negative effects

  • higher prices;
  • reduced consumer choice;
  • reduced intra-brand competition;
  • geographic price discrimination;
  • reduced arbitrage;
  • stronger distributor market power;
  • protection of inefficient distribution structures.

Potential positive effects

Some restrictions can support:

  • investment in distribution;
  • product quality;
  • after-sales services;
  • safety compliance;
  • regulatory adaptation;
  • prevention of counterfeit goods;
  • brand reputation.

Competition law therefore does not treat every restriction on parallel imports as automatically unlawful.

18. Key Doctrinal Distinction

A crucial distinction is:

"Can the IP owner legally stop the import?"

versus

"Has the IP owner used its rights in an anticompetitive manner?"

The first question is primarily one of IP law and exhaustion.

The second is a question of competition law.

The two regimes overlap but are not identical.

19. Exam-Oriented Principles

For an examination answer, the following propositions are particularly important:

  1. Parallel imports involve genuine goods entering a market outside the authorized distribution channel.
  2. Restrictions may arise from contracts, IP rights, distribution arrangements, or regulatory mechanisms.
  3. Exhaustion doctrine determines how far IP rights can be used to block subsequent circulation.
  4. Territorial market partitioning is a central competition concern.
  5. Restrictions on passive sales can be particularly problematic.
  6. Dual pricing may be scrutinized where it is designed to prevent arbitrage.
  7. Trademark, copyright and patent rights do not automatically immunize conduct from competition law.
  8. Legitimate quality, safety and regulatory objectives can justify certain restrictions.
  9. The proportionality and actual economic effects of the restriction are important.
  10. Dominant undertakings face additional scrutiny under abuse-of-dominance rules.

20. Conclusion

Parallel import restrictions sit at the intersection of intellectual-property law, distribution law and competition law. The central competition concern is that manufacturers or distributors may use territorial restrictions to divide markets, eliminate arbitrage and maintain artificially different national prices.

The leading authorities—including Consten and Grundig, United Brands, Merck, Bristol-Myers Squibb, Silhouette, Sebago, Bayer and GlaxoSmithKline—show that the legal analysis depends heavily on the applicable exhaustion regime, territorial distribution rules, nature of the restriction, market position, and legitimate commercial or regulatory justification.

LEAVE A COMMENT